Saturday, July 11, 2026

Drug profile · INN

irinotecan hydrochloride injection(campto®)

irinotecan hydrochloride injection(campto®) is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — irinotecan hydrochloride injection(campto®)
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

irinotecan hydrochloride injection(campto®) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN irinotecan hydrochloride injection(campto®)

Approval history

Authority Status Date
NMPA clinical trials

Frequently asked questions

What is irinotecan hydrochloride injection(campto®)?

irinotecan hydrochloride injection(campto®) is an FDA-listed pharmaceutical active ingredient.